|
Sign In to gain access to subscriptions and/or personal tools.
|
Migraine: New Molecular Mechanisms
Daniela Pietrobon
Department of Biomedical Sciences, University of Padova, Padova, Italy, daniela.pietrobon{at}unipd.it
Migraine is an episodic headache disorder affecting more than 10% of the general population. Migraine arises from a primary brain dysfunction that leads to activation and sensitization of the trigeminovascular system. A major incompletely understood issue in the neurobiology of migraine concerns the molecular and cellular mechanisms that underlie the primary brain dysfunction and lead to activation and sensitization of the trigeminovascular system, thus generating and maintaining migraine pain. Here the author reviews recent discoveries that have advanced our understanding of these mechanisms toward a unifying pathophysiological hypothesis, in which cortical spreading depression (CSD), the phenomenon underlying migraine aura, assumes a key role. In particular, the author discusses the main recent findings in the genetics and neurobiology of familial hemiplegic migraine and the insights they provide into the molecular and cellular mechanisms that may lead to the increased susceptibility of CSD in migraineurs.
Key Words: Migraine • Cortical spreading depression • Calcium channel • Na+ • K+-ATPase
The Neuroscientist, Vol. 11, No. 4,
373-386 (2005)
DOI: 10.1177/1073858405275554
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
A. H. Stam, B. de Vries, A. C.J.W. Janssens, K.R.J. Vanmolkot, Y. S. Aulchenko, P. Henneman, B. A. Oostra, R. R. Frants, A. M.J.M. van den Maagdenberg, M. D. Ferrari, et al.
Shared genetic factors in migraine and depression: Evidence from a genetic isolate
Neurology,
January 26, 2010;
74(4):
288 - 294.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-L. Sixt, K. Messlinger, and M. J. M. Fischer
Calcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus
Brain,
November 1, 2009;
132(11):
3134 - 3141.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J. Clapcote, S. Duffy, G. Xie, G. Kirshenbaum, A. R. Bechard, V. Rodacker Schack, J. Petersen, L. Sinai, B. J. Saab, J. P. Lerch, et al.
Mutation I810N in the {alpha}3 isoform of Na+,K+-ATPase causes impairments in the sodium pump and hyperexcitability in the CNS
PNAS,
August 18, 2009;
106(33):
14085 - 14090.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G Martella, C Costa, A Pisani, L. Cupini, G Bernardi, and P Calabresi
Antiepileptic Drugs on Calcium Currents Recorded from Cortical and PAG Neurons: Therapeutic Implications for Migraine
Cephalalgia,
December 1, 2008;
28(12):
1315 - 1326.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Thomsen, E Oestergaard, A Bjornsson, H Stefansson, A. Fasquel, J Gulcher, K Stefansson, and J Olesen
Screen for CACNA1A and ATP1A2 Mutations in Sporadic Hemiplegic Migraine Patients
Cephalalgia,
September 1, 2008;
28(9):
914 - 921.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. A. Teive, E. J. Piovesan, P. A. Kowacs, L. C. Werneck, M. R. Winawer, P. De Jonghe, L. Deprez, K. Peeters, W. Van Paesschen, K.G. Claeys, et al.
FAMILIAL OCCIPITOTEMPORAL LOBE EPILEPSY AND MIGRAINE WITH VISUAL AURA: LINKAGE TO CHROMOSOME 9Q NEW EVIDENCE FOR A GENETIC LINK BETWEEN EPILEPSY AND MIGRAINE
Neurology,
March 11, 2008;
70(11):
896 - 897.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J Haan, G. Terwindt, A. van den Maagdenberg, A. Stam, and M. Ferrari
A Review of the Genetic Relation Between Migraine and Epilepsy
Cephalalgia,
February 1, 2008;
28(2):
105 - 113.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
